SCHEDULE 13D/A

Kymera Therapeutics Inc

Common Stock, $0.0001 par value per share · CUSIP: 501575104

Event date: 2025-12-09

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares

Unavailable

Percent of class

Unavailable

• Baker Bros. Advisors LPReported CIK 0001263508

  Shares: 8,676,797.00 · Class: 10.9%

• Baker Bros. Advisors (GP) LLCReported CIK 0001580575

  Shares: 8,676,797.00 · Class: 10.9%

• Julian C. BakerReported CIK 0001087939

  Shares: 8,676,797.00 · Class: 10.9%

• Felix J. BakerReported CIK 0001087940

  Shares: 8,676,797.00 · Class: 10.9%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.